Richard S. Geary

Preventive Cardiology

Ionis Pharmaceuticals (United States)

About

Richard S. Geary works in Preventive Cardiology affiliated with Ionis Pharmaceuticals (United States).

Richard S. Geary served as the Executive Vice President and Chief Development Officer at Ionis Pharmaceuticals in the United States. He was responsible for preclinical and clinical development of antisense oligonucleotide drugs, including those for cardiovascular and metabolic conditions. He joined the company in 1995 and retired in January 2026.

Research focus

Hypertriglyceridemia managementLipoprotein(a) inhibitionANGPTL3-targeted therapyAPOC3 antisense oligonucleotidesFamilial chylomicronemia syndrome treatment

Impact

205 pubs · 14,213 cites · h-index 65

Training

Ph.D. in Biopharmaceutics
University of Texas at Austin
1987
B.S. in Biology
Texas A&M University

Affiliations

Work Experience

Executive Vice President and Chief Development Officer

Ionis Pharmaceuticals · 1995 - 2026

Senior Research Scientist and Group Leader

Southwest Research Institute · 1995